MEP25608A - Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics - Google Patents

Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics

Info

Publication number: MEP25608A
Authority: ME; Montenegro
Prior art keywords: group; formula; hydrogen atom; alkyl; benzamide
Prior art date: 2002-04-19

Application number

MEP-256/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Gihad Dargazanli

Genevieve Estenne-Bouhtou

Pascale Magat

Benoit Marabout

Florence Medaisko

Pierre Roger

Mireille Sevrin

Corinne Veronique

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-19

Filing date

2003-04-17

Publication date

2010-06-10

2003-04-17 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2010-06-10 Publication of MEP25608A publication Critical patent/MEP25608A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

MEP-256/08A 2002-04-19 2003-04-17 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics MEP25608A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0204916A FR2838739B1 (fr)	2002-04-19	2002-04-19	Derives de n-[phenyl(piperidin-2-yl)methyl)benzamide, leur preparation et leur application en therapeutique
PCT/FR2003/001232 WO2003089411A1 (fr)	2002-04-19	2003-04-17	Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
MEP25608A true MEP25608A (en)	2010-06-10

Family

ID=28686193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-256/08A MEP25608A (en)	2002-04-19	2003-04-17	Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics

Country Status (35)

Country	Link
US (2)	US7326722B2 (xx)
EP (1)	EP1499589B1 (xx)
JP (1)	JP4597532B2 (xx)
KR (2)	KR20040103973A (xx)
CN (1)	CN100482646C (xx)
AR (1)	AR039413A1 (xx)
AT (1)	ATE361279T1 (xx)
AU (1)	AU2003262420B2 (xx)
BR (1)	BR0309397A (xx)
CA (1)	CA2481461C (xx)
CO (1)	CO5631432A2 (xx)
CY (1)	CY1108025T1 (xx)
DE (1)	DE60313602T2 (xx)
DK (1)	DK1499589T3 (xx)
EA (1)	EA007225B1 (xx)
EC (1)	ECSP045369A (xx)
ES (1)	ES2286444T3 (xx)
FR (1)	FR2838739B1 (xx)
HR (1)	HRP20040977B1 (xx)
IL (2)	IL164400A0 (xx)
IS (1)	IS2540B (xx)
MA (1)	MA27192A1 (xx)
ME (1)	MEP25608A (xx)
MX (1)	MXPA04010326A (xx)
NO (1)	NO329065B1 (xx)
NZ (1)	NZ536015A (xx)
PL (1)	PL373195A1 (xx)
PT (1)	PT1499589E (xx)
RS (1)	RS51888B (xx)
SI (1)	SI1499589T1 (xx)
TN (1)	TNSN04208A1 (xx)
TW (1)	TWI306402B (xx)
UA (1)	UA78025C2 (xx)
WO (1)	WO2003089411A1 (xx)
ZA (1)	ZA200408154B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2842804B1 (fr)	2002-07-29	2004-09-03	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
FR2861074B1 (fr) *	2003-10-17	2006-04-07	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861070B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
FR2861073B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
WO2005044810A1 (en) *	2003-10-30	2005-05-19	Janssen Pharmaceutica, N.V.	Glyt2 modulators
WO2005092442A2 (en) *	2004-03-22	2005-10-06	Apkarian Vania A	Method and compositions for treatment of chronic neuropathic pain
UA88518C2 (ru)	2005-04-08	2009-10-26	Пфайзер Продактс Инк.	Бицикло[3,1,0]гетероариламиды как ингибиторы транспорта глицина типа i
JP2009179562A (ja) *	2006-08-11	2009-08-13	Taisho Pharmaceutical Co Ltd	グリシントランスポーター阻害剤
FR2917735B1 (fr) *	2007-06-21	2009-09-04	Sanofi Aventis Sa	Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique
TW200911808A (en) *	2007-07-23	2009-03-16	Astrazeneca Ab	Novel compounds
US8420670B2 (en)	2007-08-22	2013-04-16	Abbott Laboratories	4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
JP5554319B2 (ja)	2008-04-01	2014-07-23	アボットゲーエムベーハーウントカンパニーカーゲー	テトラヒドロイソキノリン類、それを含む医薬組成物および治療におけるそれの使用
WO2010087761A1 (en) *	2009-01-28	2010-08-05	Astrazeneca Ab	2-aza-bicyclo[2.2.2]octane compounds and uses thereof
TW201038569A (en)	2009-02-16	2010-11-01	Abbott Gmbh & Co Kg	Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
AR075442A1 (es)	2009-02-16	2011-03-30	Abbott Gmbh & Co Kg	Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
JP5618047B2 (ja) *	2010-01-29	2014-11-05	国立大学法人千葉大学	ポジトロン断層撮影法およびポジトロン放出化合物
US8877794B2 (en)	2010-08-13	2014-11-04	Abbott Laboratories	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en)	2010-08-13	2014-09-30	Abbott Laboratories	Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en)	2010-08-13	2015-06-02	AbbVie Deutschland GmbH & Co. KG	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en)	2010-08-13	2014-11-11	Abbott Laboratories	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en)	2010-08-13	2015-06-09	AbbVie Deutschland GmbH & Co. KG	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en)	2011-05-12	2016-04-12	AbbVie Deutschland GmbH & Co. KG	Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
JP2014517074A (ja)	2011-06-24	2014-07-17	アムジエン・インコーポレーテツド	Ｔｒｐｍ８アンタゴニストおよび治療におけるそれらの使用
JP2014527511A (ja)	2011-06-24	2014-10-16	アムジエン・インコーポレーテツド	Ｔｒｐｍ８拮抗剤及び治療におけるそれらの使用
WO2013020930A1 (en)	2011-08-05	2013-02-14	Abbott Gmbh & Co. Kg	Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2013072520A1 (en)	2011-11-18	2013-05-23	AbbVie Deutschland GmbH & Co. KG	N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
FR2983197B1 (fr) *	2011-11-29	2014-07-25	Assist Publ Hopitaux De Paris	Utilisation de phacetoperane pour traiter un trouble deficit de l'attention hyperactivite
US9365512B2 (en)	2012-02-13	2016-06-14	AbbVie Deutschland GmbH & Co. KG	Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US8952009B2 (en)	2012-08-06	2015-02-10	Amgen Inc.	Chroman derivatives as TRPM8 inhibitors
US9656955B2 (en)	2013-03-15	2017-05-23	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en)	2013-03-15	2017-05-16	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
AU2014336153A1 (en)	2013-10-17	2016-04-28	AbbVie Deutschland GmbH & Co. KG	Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2016004934A (es)	2013-10-17	2016-12-20	Abbvie Deutschland	Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
US9550754B2 (en)	2014-09-11	2017-01-24	AbbVie Deutschland GmbH & Co. KG	4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
US20170143681A1 (en)	2015-11-02	2017-05-25	Apkarian Technologies Llc	Methods and compositions for treating pain
FR3045044B1 (fr) *	2015-12-11	2019-04-19	Liphatech	Composition et appat rodonticide comprenant du flocoumafene, procede de lutte contre des rongeurs cibles nuisibles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5254569A (en) *	1991-01-14	1993-10-19	The Du Pont Merck Pharmaceutical Company	(Amidomethyl)nitrogen heterocyclic analgesics
JP3026845B2 (ja) *	1991-02-20	2000-03-27	日清製粉株式会社	ピペリジン誘導体
US5524569A (en)	1995-03-20	1996-06-11	Rich; William A.	Anchor cover
SK13092000A3 (sk) *	1998-03-06	2001-03-12	Janssen Pharmaceutica N. V.	Inhibítory prenosu glycínu, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
AU2001254546A1 (en) *	2000-04-20	2001-11-07	Nps Allelix Corp.	Aminopiperidines

2002
- 2002-04-19 FR FR0204916A patent/FR2838739B1/fr not_active Expired - Fee Related
2003
- 2003-04-15 AR ARP030101310A patent/AR039413A1/es unknown
- 2003-04-17 SI SI200330893T patent/SI1499589T1/sl unknown
- 2003-04-17 PL PL03373195A patent/PL373195A1/xx not_active IP Right Cessation
- 2003-04-17 KR KR10-2004-7016718A patent/KR20040103973A/ko not_active Application Discontinuation
- 2003-04-17 RS YU91404A patent/RS51888B/en unknown
- 2003-04-17 ME MEP-256/08A patent/MEP25608A/xx unknown
- 2003-04-17 NZ NZ536015A patent/NZ536015A/en not_active IP Right Cessation
- 2003-04-17 KR KR1020087018794A patent/KR101019313B1/ko not_active IP Right Cessation
- 2003-04-17 IL IL16440003A patent/IL164400A0/xx unknown
- 2003-04-17 WO PCT/FR2003/001232 patent/WO2003089411A1/fr active IP Right Grant
- 2003-04-17 DK DK03740634T patent/DK1499589T3/da active
- 2003-04-17 AU AU2003262420A patent/AU2003262420B2/en not_active Ceased
- 2003-04-17 AT AT03740634T patent/ATE361279T1/de active
- 2003-04-17 MX MXPA04010326A patent/MXPA04010326A/es active IP Right Grant
- 2003-04-17 BR BR0309397-2A patent/BR0309397A/pt not_active IP Right Cessation
- 2003-04-17 CA CA002481461A patent/CA2481461C/en not_active Expired - Fee Related
- 2003-04-17 EA EA200401172A patent/EA007225B1/ru not_active IP Right Cessation
- 2003-04-17 UA UA20041008110A patent/UA78025C2/uk unknown
- 2003-04-17 CN CNB038140063A patent/CN100482646C/zh not_active Expired - Fee Related
- 2003-04-17 JP JP2003586132A patent/JP4597532B2/ja not_active Expired - Fee Related
- 2003-04-17 EP EP03740634A patent/EP1499589B1/fr not_active Expired - Lifetime
- 2003-04-17 DE DE60313602T patent/DE60313602T2/de not_active Expired - Lifetime
- 2003-04-17 PT PT03740634T patent/PT1499589E/pt unknown
- 2003-04-17 ES ES03740634T patent/ES2286444T3/es not_active Expired - Lifetime
- 2003-04-17 US US10/511,886 patent/US7326722B2/en not_active Expired - Fee Related
- 2003-04-18 TW TW092109074A patent/TWI306402B/zh not_active IP Right Cessation
2004
- 2004-09-30 IS IS7479A patent/IS2540B/is unknown
- 2004-10-04 IL IL164400A patent/IL164400A/en not_active IP Right Cessation
- 2004-10-07 MA MA27892A patent/MA27192A1/fr unknown
- 2004-10-08 ZA ZA200408154A patent/ZA200408154B/en unknown
- 2004-10-14 CO CO04103284A patent/CO5631432A2/es not_active Application Discontinuation
- 2004-10-15 NO NO20044388A patent/NO329065B1/no not_active IP Right Cessation
- 2004-10-18 TN TNP2004000208A patent/TNSN04208A1/fr unknown
- 2004-10-18 HR HR20040977A patent/HRP20040977B1/xx not_active IP Right Cessation
- 2004-10-18 EC EC2004005369A patent/ECSP045369A/es unknown
2007
- 2007-04-03 US US11/695,912 patent/US20070197601A1/en not_active Abandoned
- 2007-07-24 CY CY20071100988T patent/CY1108025T1/el unknown

Also Published As

Publication number	Publication date
BR0309397A (pt)	2005-03-01
AU2003262420A1 (en)	2003-11-03
ATE361279T1 (de)	2007-05-15
AR039413A1 (es)	2005-02-16
IL164400A (en)	2010-11-30
US7326722B2 (en)	2008-02-05
PL373195A1 (en)	2005-08-22
AU2003262420B2 (en)	2009-02-19
RS51888B (en)	2012-02-29
EA007225B1 (ru)	2006-08-25
ECSP045369A (es)	2005-03-10
IS2540B (is)	2009-09-15
CA2481461A1 (en)	2003-10-30
DE60313602T2 (de)	2008-01-10
CN100482646C (zh)	2009-04-29
SI1499589T1 (sl)	2007-10-31
FR2838739A1 (fr)	2003-10-24
NO20044388L (no)	2005-01-19
ZA200408154B (en)	2005-10-10
WO2003089411A1 (fr)	2003-10-30
US20050159450A1 (en)	2005-07-21
RS91404A (xx)	2007-02-05
CY1108025T1 (el)	2013-09-04
JP4597532B2 (ja)	2010-12-15
ES2286444T3 (es)	2007-12-01
HRP20040977B1 (en)	2008-04-30
FR2838739B1 (fr)	2004-05-28
MA27192A1 (fr)	2005-01-03
NO329065B1 (no)	2010-08-09
EP1499589B1 (fr)	2007-05-02
UA78025C2 (en)	2007-02-15
IL164400A0 (en)	2005-12-18
US20070197601A1 (en)	2007-08-23
CN1662497A (zh)	2005-08-31
JP2005527593A (ja)	2005-09-15
EA200401172A1 (ru)	2005-04-28
HRP20040977A2 (en)	2004-12-31
DE60313602D1 (de)	2007-06-14
PT1499589E (pt)	2007-08-10
KR101019313B1 (ko)	2011-03-07
DK1499589T3 (da)	2007-09-10
CO5631432A2 (es)	2006-04-28
MXPA04010326A (es)	2005-07-05
IS7479A (is)	2004-09-30
KR20080075236A (ko)	2008-08-14
TNSN04208A1 (fr)	2007-03-12
CA2481461C (en)	2010-01-12
NZ536015A (en)	2006-11-30
EP1499589A1 (fr)	2005-01-26
TW200306830A (en)	2003-12-01
TWI306402B (en)	2009-02-21
KR20040103973A (ko)	2004-12-09

Publication	Publication Date	Title
MEP25608A (en)	2010-06-10	Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
MEP12708A (en)	2010-06-10	Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics
MEP12608A (en)	2010-06-10	Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
FR2842804B1 (fr)	2004-09-03	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
MEP22008A (en)	2010-06-10	Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
ES2121441T3 (es)	1998-11-16	Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
HUP0301607A2 (hu)	2003-12-29	Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BR9611618A (pt)	1999-03-30	Composto processo para sua preparação composição farmacêutica e utilização de um compostos
HUP0300350A2 (hu)	2003-06-28	Új 3-amino-azetidin-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
DE60033964D1 (de)	2007-04-26	Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
MEP24208A (en)	2010-06-10	Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
YU40998A (sh)	1999-09-27	Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
RS51462B (en)	2011-04-30	TRIAZOLOPYRIDINE CARBOXAMID DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION
HRP20070286T3 (en)	2007-08-31	Substituted diketopiperazines and their use as oxytocyn antagonists
SE9703375D0 (sv)	1997-09-18	A new combination
SE9703377D0 (sv)	1997-09-18	New compounds
HRP20040230B1 (en)	2012-01-31	Muscarinic agonists
HRP20030610B1 (en)	2006-02-28	Process for the preparation of mesylates of piperazine derivatives
ATE550332T1 (de)	2012-04-15	4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
HUP0203332A2 (hu)	2003-01-28	Ciklotiokarbamát-származékok, progeszteron receptor modulátorokként való alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
MEP12108A (en)	2010-06-10	Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
ATE184593T1 (de)	1999-10-15	Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
HUP9904210A2 (hu)	2000-05-28	Kamptotecin-analógok, alkalmazásuk gyógyszerként és ilyen vegyületeket tartalmazó gyógyászati készítmények
RS51504B (en)	2011-06-30	FUNGICID COMPOSITIONS BASED ON PIRIDYL METHYLBENZAMIDE DERIVATIVES AND PROPAMOCARB
ATE195517T1 (de)	2000-09-15	Chinolinonderivate und diese enthaltende antiallergische zusammensetzungen